The alarming global rise in fatalities from multidrug-resistant <i>Staphylococcus aureus</i> (<i>S. aureus</i>) infections has underscored a need to develop new therapies to address this epidemic. Chemoproteomics is valuable in identifying targets for new drugs in different human diseases including bacterial infections. Targeting functional cysteines is particularly attractive, as they serve critical catalytic functions that enable bacterial survival. Here, we report an indole-based quinone epoxide scaffold with a unique boat-like conformation that allows steric control in modulating thiol reactivity. We extensively characterize a lead compound (<b>4a</b>), which potently inhibits clinically derived vancomycin-resistant <i>S. aureus</i>. Leveraging diverse chemoproteomic platforms, we identify and biochemically validate important transcriptional factors as potent targets of <b>4a</b>. Interestingly, each identified transcriptional factor has a conserved catalytic cysteine residue that confers antibiotic tolerance to these bacteria. Thus, the chemical tools and biological targets that we describe here prospect new therapeutic paradigms in combatting <i>S. aureus</i> infections.